Vijay Kumar Evercore ISI Group Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
91
Avg Return
Past Year
Past Year
2.8%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
69.2%
Neutral
30.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Industrials
Technology
Financials
Banks - Regional
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Medical Devices
Medical Instruments & Supplies
Industrials
Integrated Freight & Logistics
Technology
Scientific & Technical Instruments
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $34 |
77%
upside
| 3 | -8.1% |
0
%
| 27 Feb ‘26 6 days ago |
|
|
|
Outperform
Maintained
| $360 |
6%
upside
| 3 | +8.8% |
0
%
| 26 Feb ‘26 7 days ago |
|
|
|
In-Line
Maintained
| $65 |
22%
upside
| 4 | – |
–
| 5 Feb ‘26 28 days ago |
|
|
|
Outperform
Maintained
| $98 |
29%
upside
| 3 | +3% |
0
%
| 5 Feb ‘26 28 days ago |
|
|
|
Outperform
Maintained
| $96 |
33%
upside
| 3 | -9.9% |
0
%
| 5 Feb ‘26 28 days ago |
|
|
|
Outperform
Maintained
| $45 |
82%
upside
| 4 | -14% |
0
%
| 5 Feb ‘26 28 days ago |
|
|
|
Outperform
Maintained
| $52 |
7%
upside
| 2 | +25% |
0
%
| 3 Feb ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $118 |
23%
upside
| 3 | -0.45% |
0
%
| 3 Feb ‘26 1 month ago |
|
|
|
In-Line
Maintained
| $550 |
12%
upside
| 4 | – |
–
| 23 Jan ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $138 |
25%
upside
| 6 | -1.9% |
0
%
| 23 Jan ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $223 |
2%
downside
| 3 | +20% |
0
%
| 13 Jan ‘26 1 month ago |
|
|
|
In-Line
Downgraded
| $78 |
3%
upside
| 4 | +11% |
0
%
| 5 Jan ‘26 1 month ago |
|
|
|
In-Line
Downgraded
| $105 |
1%
upside
| 5 | +26% |
0
%
| 5 Jan ‘26 1 month ago |
|
|
|
In-Line
Downgraded
| $18 |
3%
upside
| 5 | +9.6% |
0
%
| 5 Jan ‘26 1 month ago |
|
|
|
In-Line
Downgraded
| $12 |
42%
upside
| 3 | +0.45% |
0
%
| 5 Jan ‘26 1 month ago |
|
|
|
Outperform
Upgraded
| $120 |
29%
upside
| 3 | +4.2% |
0
%
| 5 Jan ‘26 1 month ago |
|
|
|
Outperform
Upgraded
| $210 |
67%
upside
| 3 | -28% |
0
%
| 5 Jan ‘26 1 month ago |
|
|
|
Outperform
Upgraded
| $160 |
36%
upside
| 5 | -15% |
0
%
| 5 Jan ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $405 |
10%
upside
| 4 | -0.17% |
0
%
| 31 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $142 |
10%
upside
| 3 | +11% |
0
%
| 31 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $92 |
11%
upside
| 4 | +4.6% |
0
%
| 31 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $590 |
15%
upside
| 3 | +7.1% |
0
%
| 7 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $1,400 |
12%
upside
| 3 | +2.3% |
0
%
| 7 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $245 |
22%
upside
| 2 | +0.44% |
0
%
| 7 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $31 |
68%
upside
| 2 | -21% |
0
%
| 7 Oct ‘25 4 months ago |
|